We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
This notice is aimed at small businesses and individuals who may wish to use digital or photographic images on the web.
Add an image or video to GOV.UK.
Bristol-Myers Squibb Pharmaceuticals Limited has informed the MHRA that a potential product quality issue has been detected, relating to incomplete crimping of the metal crimp cap of OPDIVO 10mg/mL concentrate for solution for infusion (nivolumab) (1VLX10ML).
Importance of land use changes study in monitoring and assessing ecosystems
This playbook explains how we use social media at GDS. In it, we share our best practice, what we've learned and what we're planning to do.
Abusers who share intimate images without consent to face up to 6 months in prison.
Employment Appeal Tribunal Judgment of Mrs Justice Eady on 18 April 2024.
Report internet content promoting terrorism, extremism or violence - your report will be treated anonymously.
This is a list of the RPC's Register of Interests for 2022
Keep up to date with the UK policy development in respect of Standard Essential Patents.
Browse cases data for specific areas within the UK.
Novartis Pharmaceuticals UK Limited is recalling Adakveo 10 mg/ml concentrate for solution for infusion due to the benefit-risk balance of Adakveo no longer being considered favourable by the MHRA.
Legislation title: Guidance on the application of Plant Protection Products (PPPs) for phytosanitary treatment of oak processionary moth (OPM).
Use a separate statement of objection form for each Japanese GI product name you object to.
Volume 23 of the non-technical summaries granted under the Animals (Scientific Procedures) Act 1986 during 2013.
Volume 4 of the non-technical summaries granted under the Animals (Scientific Procedures) Act 1986 during 2013.
Decision for applicant Xerox Corporation and Xerox Limited registration number 14948448, applicant successful.
Volume 39 of the non-technical summaries granted under the Animals (Scientific Procedures) Act 1986 during 2013.
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. We’ll send you a link to a feedback form. It will take only 2 minutes to fill in. Don’t worry we won’t send you spam or share your email address with anyone.